Australian Securities Exchange Companies Announcements Office Exchange Centre
Level 6
20 Bridge Street
Sydney, NSW 2000
20 February 2013

Bioxyne completes Share Placement to raise up to $508,000 ("Placement") Key Highlights

• Placement completed.

• Placement to raise $508,371, with the issue of 23,107,772 shares at 2.2 cents. Each new share will be entitled to a 1 for 2 attaching option, exercisable at 4 cents with an expiry date of 31 March 2015.

• The new shares will be allotted on settlement, scheduled for 25 February 2013.

• The Placement was fully underwritten.


The Directors of Bioxyne Limited (BXN or the Company) are pleased to announce that the Placement to raise up to $508,371 and the issue of 23,107,772 shares, being 15% of the Company's issued equity, was successfully completed within short period of time.
The book build price for the Placement was 2.2 cents per share, plus a 1 for 2 free attaching option, exercisable at 4 cents, with an expiry date of 31 March 2015 (Option). The Option is subject to shareholder approval, which is expected to take place with the approval of the acquisition of VIALITY Devices Pty Limited (VIALITY).
The new shares will be allotted on settlement, scheduled for 25 February 2013.
The Placements shares were underwritten by Veritas Securities Limited and by a major shareholder Phillip Asset Management Limited.
For more information, contact
Jarrod White
Chief Financial Officer
Mobile: 0401 876 996

1

distributed by